Beleaguered Novo offers relief to investors, thanks to Wegovy pill

A finance story from the U.S., reported by MarketWatch.

Finance · the U.S. · November 4, 2026

From MarketWatch

Novo Nordisk stock jumped higher on Wednesday as the Danish drugmaker lifted its guidance on strong uptake of its weight-loss drug pill that has been launched this year.

Reported by MarketWatch, November 4, 2026. Read the full story at MarketWatch →

More finance from the U.S.

Euro zone inflation hits 4% for first time in three years as interest rate hike looms · CNBC Markets
CEOs need a new playbook after a midterm rebuke of Trump · Fortune
‘My life could be cut short’: I’m 55, married with $4.3 million and have a brain tumor. Should I buy a $210,000 custom Porsche? · MarketWatch
Housing Market Feels the Chill as Buyers Pull Back—but Sellers Are Not Panicking Yet · Realtor.com News
Jordyn Woods on her baby plans with Karl-Anthony Towns after buying $14 million home · MarketWatch
5 midterm election takeaways: Tech billionaires suffer as Democrats drub Republicans · CNBC Top News
What Trump losing power over Congress means for Iran, Ukraine and foreign policy · CNBC Top News
Gold, silver and precious metals prices jump, dollar dips as Democrats take control of Congress · CNBC Top News

All finance →

Open HeyHomees →